During the past decade, Hays Medical Center Dreiling-Schmidt Cancer Institute conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hays Medical Center Dreiling-Schmidt Cancer Institute" are "Breast Cancer" (2 trials), "Gastrointestinal Cancer" (1 trials) and "Hereditary Breast and Ovarian Cancer" (1 trials). Many other conditions were trialed in "Hays Medical Center Dreiling-Schmidt Cancer Institute" in a lesser frequency.

Most popular intervention types in "Hays Medical Center Dreiling-Schmidt Cancer Institute" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Capecitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hays Medical Center Dreiling-Schmidt Cancer Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hays Medical Center Dreiling-Schmidt Cancer Institute". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Hays Medical Center Dreiling-Schmidt Cancer Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hays Medical Center Dreiling-Schmidt Cancer Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".